The human B cell line RPMI 8226 exhibits variable staining with the CD
14 antibody My4. We have isolated three stable clones from this line w
ith clones 1 and 2 being My4 positive and clone 3 My4 negative. Simila
r to previous results in monocytes, immunoprecipitation with the My4 a
ntibody revealed a 54-kDa cell surface molecule, analysis of supernata
nts showed soluble CD14, and Northern blotting demonstrated a 1.4-kb t
ranscript in clones 1 and 2, but not in clone 3, which suggests that t
he My4 antibody detects CD14 in clones 1 and 2. This CD14 molecule was
functional in that lipopolysaccharide stimulation induced interleukin
(IL)-6 and IL-10 in clones 1 and 2 but not in clone 3. Furthermore, t
he My4 antibody was capable of blocking these responses at the transcr
ipt and protein levels. Finally, peripheral blood B cells were highly
purified by cell sorting (> 98% CD19 positive). These cells produced I
L-6 in response to lipopolysaccharide, and this response was blocked b
y anti-CD14 antiserum. Thus, our findings demonstrated that human B ce
lls can express functionally active CD14.